Homoharringtonine in combination with cytarabine and aclarubicin as induction therapy improves remission and survival of patients with higher risk myelodysplastic syndromes.
作者信息
Xu Wei-lai, Jin Jie, Qian Wen-bin
机构信息
Institute of Hematology, First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
出版信息
Chin Med J (Engl). 2010 Jan 5;123(1):108-10.
PMID:20137586
Abstract
摘要
Zotero 插件